With increasing local cases of COVID-191 it is crucial Aged Care Service Providers stay informed on updates that will impact vulnerable populations, in particular those aged 75 years or older.
Pitch Night is back in 2024, with Hunter New England and Central Coast Primary Health Network (HNECC PHN) and The Funding Network (TFN) hosting two live crowdfunding events in April at Lake Macquarie and Tamworth. The events will support four organisations to share their story and raise vital program funds so they can localise their suicide prevention pilot projects to support our communities.
Forecasters are warning the upcoming summer season will be both hotter and dryer than in recent years. With that in mind, the PHN is urging Hunter, New England and Central Coast residents to be prepared, stay informed and know their options.
The PHN is informing primary care providers that on 24/11/2023, the Public Health and Surveillance Branch in the Office of Health Protection of the Department of Health and Aged Care has issued a quarantine notice for the product; InterPharma Sodium Chloride 0.9% 10ml or 30ml ampoules.
Before heading overseas these holidays, we are asking Australians to add vaccinations to their travel checklist.
Do you work with people with heart disease? We want to know your perceptions on using genetics to inform nutrition interventions.
The PHN has been working on reducing the burden of reporting for Commissioned Services. Part of this project was the introduction of a consistent validated Participant Reported Experience Measure (PREM) administered by Cemplicity, who will administer, collate and report the YES PHN Survey. Commissioned services are in the process of adopting this as new process.
Changes to ATAGI guidelines: Monovalent COVID-19 vaccines - As our regions faces increasing numbers of COVID-19 cases, the Australian Technical Advisory Group on Immunisation (ATAGI) has issued updated advice regarding the use of Monovalent Omicron XBB.1.5 COVID-19 vaccines.
NSW Health has recently introduced a second universal antenatal syphilis screen at 26-28 weeks gestation and additional screening for women at high-risk of syphilis in pregnancy. This is in response to concerning increases in maternal and congenital syphilis diagnosed in NSW.
From 1 November 2023, the varicella virus recombinant vaccine, Shingrix ®, replaces Zostavax®, on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It is available for eligible people most at risk of complications from shingles (1). The program changes follow recommendations from the Pharmaceutical Benefits Advisory Committee, the Australian Technical Advisory Group on Immunisation (ATAGI) and other clinical experts (1).